Tag: research

Novel Genetic Findings for Myeloproliferative Neoplasms

Dave Hinds is a Principal Scientist in Statistical Genetics.  Editor's note: This post has been edited from its original to reflect changes in 23andMe's product. 23andMe is passionate about research on a group of rare blood disorders called myeloproliferative neoplasms, or MPNs. Physicians who study these ...

Read more

The Genetics of Nearsightedness, Stretch Marks, and Motion Sickness

Amy Kiefer is a Survey Research Manager at 23andMe. She joined the company in 2008. What do nearsightedness, stretch marks, and motion sickness have to do with each other? They don’t appear to be genetically related — at least not according to our in-house statistical geneticists — but all of them are ...

Read more

A Milestone in the Fight Against MPNs Marks a Moment to Reflect

Ashley Gould, 23andMe's Vice President Corporate Development and Chief Legal Officer We recently topped our goal of enrolling 1,000 people with a group of rare blood disorders known as myeloproliferative neoplasms, or MPNs. As a testament to the passion of the people who’ve enrolled in our MPN Research ...

Read more

Fighting Rare Blood Cancers

Dr. Ross Levine Last year 23andMe launched a Myeloproliferative Neoplasms Research Initiative to study this group of rare blood cancers. We are now very close to reaching our goal of enrolling 1,000 patients and are encouraged by what we’ve already learned. We’re also humbled that another star in the ...

Read more

Participating in Genetic Research

Not all cancers are created equal. Ask anyone with metastatic breast cancer. For the 155,000 women in the United States living with this diagnosis, each day represents a constant fight against a cancer that has spread into other parts of their bodies — most often their bones, liver, lungs or brain. With ...

Read more

A Milestone in Sarcoma Research

Each person who has joined 23andMe’s Sarcoma research community has their own reasons for participating, but they all share the same hopes that we have — to find the causes for sarcoma and new treatments for this rare cancer. Earlier this month, 23andMe took an important step in that direction when we ...

Read more

Leveraging The Direct-to-Patient Research Model in Rheumatoid Arthritis

Janssen Healthcare Innovation, a unit of Janssen Research & Development, LLC, is sponsoring a study in rheumatoid arthritis patients that will be conducted by MediGuard.org (a subsidiary of Quintiles) and 23andMe. The study, called TogetherRA, will enroll approximately 1,000 patients who are currently ...

Read more

CureTogether with 23andMe

23andMe is passionate about making discoveries that will benefit you. We give individuals access to their DNA data while in turn translating information they’ve volunteered into meaningful genetic discoveries. Today we’re announcing the acquisition of CureTogether, Inc. a company that we’ve admired ...

Read more

Fighting Cancer Together

The American Society of Clinical Oncology recently wrapped up its annual meeting, bringing together health care professionals focused on the fight against cancer. The five days were packed with mind-expanding science and encouraging updates on new efforts for research collaboration between doctors, ...

Read more

23andMe to Present Data from Sarcoma Research at Oncology Conference

Starting today cancer researchers will be gathering in Chicago at the meeting of the American Society of Clinical Oncology. Researchers and doctors at the annual meeting — the world’s largest oncology conference — will hear about the most promising drugs being developed to fight cancer. They’ll spend five ...

Read more

Return to top